Dr. Joseph Skitzki
Meet Dr. Skitzki
Schedule a Conversation
The surgeon or staff member will make their best effort to call you at your requested time. If they become unavailable, you will receive a text/email to reschedule.
Joseph J. Skitzki, MD, FACS, joined the faculty of Roswell Park Cancer Institute in 2009 and is an Associate Professor of Surgical Oncology and Associate Member of the Immunology Department. He is also an Associate Professor of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo.
Dr. Skitzki earned his medical degree from the Pennsylvania State University’s College of Medicine, Hershey, where he was inducted into the Alpha Omega Alpha Medical Honor Society. He completed a general surgery residency at Case Western Reserve University, Cleveland. Within his residency, Dr. Skitzki completed a two-year research fellowship in surgical oncology at the University of Michigan, Ann Arbor. He is a Diplomate of the American Board of Surgery and a Fellow in the American College of Surgeons. He holds membership in the Society of Surgical Oncology, American Society of Clinical Oncology, American Association for Cancer Research, American Society of Peritoneal Surface Malignancies, and the Association for Academic Surgery.
Dr. Skitzki is clinically active in the areas of melanoma and sarcoma with a focus on regional therapies. His independent lab focuses on immunotherapies for melanoma and animal modeling of regional therapies with the goal of clinical translation. Dr. Skitzki has authored or co-authored more than 50 journal publications, book chapters and abstracts.
Heated Chemotherapy After Surgery Greatly Extends Lives of Patients with Some Advanced Colorectal Cancers The past several years of cancer research have been both exciting and promising. Recent developments have allowed us to take steps in improving many cancer treatments. I believe this momentum will continue to accelerate exponentially. One research project that has offered us considerable hope was a study my colleagues and I conducted between 2003 and 2011. We looked at our results of 112 patient cases to see the immediate and long-term effects of, at the time, a newly developed procedure. The procedure, cytoreductive surgery combined with...
Laurie Barclay, MD Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS/HIPEC) appears to be safe and effective for select patients with advanced abdominal cancers, according to a retrospective analysis published in the June issue of Cancer Medicine. “There has been much discussion as to whether there is a benefit with this procedure, and historically it has been associated with a lot of risk,” senior author Joseph J. Skitzki, MD, a surgical oncologist at Roswell Park Cancer Institute in Buffalo, New York, said in a news release. “However, reviewing our data in patients treated with CS/HIPEC over the last decade showed a...
Dr. Joseph Skitzki
Have some Questions?
The contact form located on this page is the best way to get in touch with Dr. Joseph Skitzki concerning a personalized HIPEC conversation. The surgeon or their office will make every effort to contact you as soon as possible.
To have a conversation about the HIPEC procedure you do not need a referral from a doctor. There is no charge for an initial conversation.
View Contact Information
Phone: 716 845 3284